Replication of breast cancer GWAS susceptibility loci in the women's health initiative African American SHARe study

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 9, 2011, Pages 1950-1959

  Hutter, Carolyn M ^a   Young, Alicia M ^a   Ochs Balcom, Heather M ^b   Carty, Cara L ^a   Wang, Tao ^c   Chen, Christina T L ^a   Rohan, Thomas E ^c   Kooperberg, Charles ^a   Peters, Ulrike ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER INVASION; CANCER RISK; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 16Q; CONTROLLED STUDY; EUROPE; FAMILY HISTORY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; POPULATION; POSTMENOPAUSE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; AGED; BREAST NEOPLASMS; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80052533624     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0524     Document Type: Article

References (50)

1. Jemal A., Siegel R., Xu J.Q., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Chlebowski R.T., Chen Z., Anderson G.L., Rohan T., Aragaki A., Lane D., et al. Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst 2005;97:439-448
3. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. Lancet 2001;358:1389-1399
4. Stratton M.R., Rahman N. The emerging landscape of breast cancer susceptibility. Nat Genet 2008;40:17-22.
5. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M., Mehta J.P., Collins F.S., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009;106:9362-9367
6. Manolio T.A. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010;363:166-176
7. Ahmed S., Thomas G., Ghoussaini M., Healey C.S., Humphreys M.K., Platte R., et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009;41:585-590
8. Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D.P., Thompson D., Ballinger D.G., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007;447:1087-1087
9. Gold B., Kirchhoff T., Stefanov S., Lautenberger J., Viale A., Garber J., et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22-33. Proc Natl Acad Sci U S A 2008;105:4340-4345 (Pubitemid 351754382)
10. Hunter D.J., Kraft P., Jacobs K.B., Cox D.G., Yeager M., Hankinson S.E., et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007;39:870-874 (Pubitemid 47014500)
11. Long J.R., Cai Q.Y., Shu X.O., Qu S.M., Li C., Zheng Y., et al. Identification of a functional genetic variant at 16q12.1 for breast cancer risk: Results from the Asia Breast Cancer Consortium. PLoS Genet 2010;6:e1001002.
12. Stacey S.N., Manolescu A., Sulem P., Rafnar T., Gudmundsson J., Gudjonsson S.A., et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007;39:865-869 (Pubitemid 47014497)
13. Stacey S.N., Manolescu A., Sulem P., Thorlacius S., Gudjonsson S.A., Jonsson G.F., et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2008;40:703-706 (Pubitemid 351748861)
14. Thomas G., Jacobs K.B., Kraft P., Yeager M., Wacholder S., Cox D.G., et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 2009;41:579-584
15. Turnbull C., Ahmed S., Morrison J., Pernet D., Renwick A., Maranian M., et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010;42:504-547
16. Zheng W., Long J.R., Gao Y.T., Li C., Zheng Y., Xiang Y.B., et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 2009;41:324-328
17. Long J.R., Shu X.O., Cai Q.Y., Gao Y.T., Zheng Y., Li G.L., et al. Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev 2010;19:2357-2365
18. Slattery M.L., Baumgartner K.B., Giuliano A.R., Byers T., Herrick J.S., Wolff RK. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States. Breast Cancer Res Treat 2011 Epub 2011 April 5. PubMed PMID: 21475998.
19. Barnholtz-Sloan J.S., Shetty P.B., Guan X.W., Nyante S.J., Luo J.C., Brennan D.J., et al. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Carcinogenesis 2010;31:1417-1423
20. Chen F., Stram D.O., Le Marchand L., Monroe K.R., Kolonel L.N., Henderson B.E., et al. Caution in generalizing known genetic risk markers for breast cancer across all ethnic/racial populations. Eur J Hum Genet 2011;19:243-245
21. Ruiz-Narvaez E.A., Rosenberg L., Rotimi C.N., Cupples L.A., Boggs D.A., Adeyemo A., et al. Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: The Black Women's Health Study. Breast Cancer Res Treat 2010;123:525-530
22. Ruiz-Narvaez E.A., Rosenberg L., Cozier Y.C., Cupples L.A., Adams-Campbell L.L., Palmer J.R. Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women. Cancer Epidemiol Biomarkers Prev 2010;19:1320-1327
23. Udler M.S., Meyer K.B., Pooley K.A., Karlins E., Struewing J.P., Zhang J., et al. FGFR2 variants and breast cancer risk: Fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet 2009;18:1692-1703
24. Zheng W., Cai Q.Y., Signorello L.B., Long J.R., Hargreaves M.K., Deming S.L., et al. Evaluation of 11 breast cancer susceptibility loci in African-American women. Cancer Epidemiol Biomarkers Prev 2009;18:2761-2764
25. Prentice R.L., Anderson G., Cummings S., Freedman L.S., Furberg C., Henderson M., et al. Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin Trials 1998;19:61-109. (Pubitemid 28085557)
26. Hays J., Hunt J.R., Hubbell F.A., Anderson G.L., Limacher M., Allen C., et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol 2003;13:S18-S77 (Pubitemid 37324176)
27. Chlebowski R.T., Hendrix S.L., Langer R.D., Stefanick M.L., Gass M., Lane D., et al. Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women-The Women's Health Initiative Randomized trial. JAMA 2003;289:3243-3253 (Pubitemid 37430077)
28. Curb J.D., McTiernan A., Heckbert S.R., Kooperberg C., Stanford J., Nevitt M., et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003;13:S122-S128 (Pubitemid 37324181)
29. Li Y., Willer C.J., Ding J., Scheet P., Abecasis G.R. MaCH: Using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010;34:816-834
30. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909 (Pubitemid 44141658)
31. Tang H., Peng J., Wang P., Risch N.J. Estimation of individual admixture: Analytical and study design considerations. Genet Epidemiol 2005;28:289-301. (Pubitemid 40559542)
32. Hindorff L.A., Junkins H.A., Hall P.N., Mehta J.P., Manolio TA. A Catalog of Published Genome-Wide Association Studies [Internet; accessed 2011 March 1]. Available from: http://www.genome.gov/gwastudies.
33. Batch Genome Variation Server [Internet; updated 2010 June 27; cited 2011 March 1]. Available from: http://gvsbatch.gs.washington.edu/GVSBatch.
34. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., De Bakker P.I.W., Chen H., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331-1336 (Pubitemid 46871653)
35. Yuan S.H., Qiu Z.L., Ghosh A. TOX3 regulates calcium-dependent transcription in neurons. Proc Natl Acad Sci U S A 2009;106:2909-2914
36. Dittmer S., Kovacs Z., Yuan S.H., Siszler G., Kogl M., Summer H., et al. TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex. J Cell Sci 2011;124:252-260
37. Udler M.S., Ahmed S., Healey C.S., Meyer K., Struewing J., Maranian M., et al. Fine scale mapping of the breast cancer 16q12 locus. Hum Mol Genet 2010;19:2507-2515
38. Bryc K., Auton A., Nelson M.R., Oksenberg J.R., Hauser S.L., Williams S., et al. Genome-wide patterns of population structure and admixture in West Africans and African Americans. Proc Natl Acad Sci U S A 2010;107:786-791
39. Tishkoff S.A., Reed F.A., Friedlaender F.R., Ehret C., Ranciaro A., Froment A., et al. The Genetic structure and history of Africans and African Americans. Science 2009;324:1035-1044
40. Eswarakumar V.P., Lax I., Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005;16:139-149 (Pubitemid 40616112)
41. Lu P.F., Ewald A.J., Martin G.R., Werb Z. Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. Dev Biol 2008;321:77-87.
42. Parsa S., Ramasamy S.K., De Langhe S., Gupte V.V., Haigh J.J., Medina D., et al. Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling. Dev Biol 2008;317:121-131
43. Martin A.J., Grant A., Ashfield A.M., Palmer C.N., Baker L., Quinlan P.R., et al. FGFR2 protein expression in breast cancer: Nuclear localisation and correlation with patient genotype. BMC Res Notes 2011;4:72.
44. Travis R.C., Reeves G.K., Green J., Bull D., Tipper S.J., Baker K., et al. Gene-environment interactions in 7610 women with breast cancer: Prospective evidence from the Million Women Study. Lancet 2010;375:2143-2151
45. Antoniou A.C., Wang X.S., Fredericksen Z.S., McGuffog L., Tarrell R., Sinilnikova O.M., et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 2010;42:885-892
46. Li C., Malone K.E., Daling J.R. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 2002;11:601-607 (Pubitemid 34760817)
47. Hao K., Chudin E., McElwee J., Schadt E.E. Accuracy of genome-wide imputation of untyped markers and impacts on statistical power for association studies. BMC Genet 2009;10:27.
48. Price A.L., Zaitlen N.A., Reich D., Patterson N.J. New approaches to population stratification in genome-wide association studies. Nat Rev Genet 2010;11:459-463
49. Chang B.L., Spangler E., Gallagher S., Haiman C.A., Henderson B.E., Isaacs W., et al. Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiol Biomarkers Prev 2011;20:23-32.
50. He J., Wilkens L.R., Stram D.O., Kolonel L.K., Henderson B.E., Wu A.H., et al. Generalizability and epidemiologic characterization of eleven colorectal cancer GWAS hits in multiple populations. Cancer Epidemiol Biomarkers Prev 2011;20:70-81.